GoodRx (NASDAQ:GDRX) Shares Up 10.5% - Here's Why

Key Points

• GoodRx shares rose by 10.5% during mid-day trading, reaching a high of $4.50 before closing at $4.85, despite a 68% drop in trading volume compared to the average.
• Analysts have mixed ratings on GoodRx, with Deutsche Bank maintaining a "hold" rating and a price target of $6, while Raymond James downgraded the stock from "strong-buy" to "outperform."
• The company reported earnings per share (EPS) of $0.09, missing the consensus estimate of $0.10 and achieving a revenue of $203.07 million, lower than the forecasted $205.72 million.

GoodRx Holdings, Inc. (NASDAQ:GDRX - Get Free Report) shares shot up 10.5% during mid-day trading on Thursday . The company traded as high as $4.50 and last traded at $4.85. 694,635 shares were traded during mid-day trading, a decline of 68% from the average session volume of 2,198,908 shares. The stock had previously closed at $4.39.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on GDRX. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $6.00 price target on shares of GoodRx in a report on Monday, August 11th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of GoodRx in a report on Wednesday. Finally, Raymond James Financial downgraded GoodRx from a "strong-buy" rating to an "outperform" rating in a report on Friday, August 8th. Five investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $5.80.

GoodRx Trading Up 5.7%

The company has a fifty day moving average of $4.22 and a two-hundred day moving average of $4.39. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of 46.40, a P/E/G ratio of 1.91 and a beta of 1.23. The company has a quick ratio of 4.21, a current ratio of 4.21 and a debt-to-equity ratio of 0.75.

GoodRx (NASDAQ:GDRX - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.01). The business had revenue of $203.07 million during the quarter, compared to analysts' expectations of $205.72 million. GoodRx had a return on equity of 8.86% and a net margin of 4.33%.The company's revenue was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.08 EPS. On average, research analysts expect that GoodRx Holdings, Inc. will post 0.13 EPS for the current year.

Insider Buying and Selling at GoodRx

In other news, major shareholder Equity Vii L.P. Spectrum sold 16,016 shares of the firm's stock in a transaction on Friday, September 5th. The stock was sold at an average price of $4.05, for a total value of $64,864.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 4.53% of the stock is currently owned by corporate insiders.

Institutional Trading of GoodRx

A number of large investors have recently made changes to their positions in GDRX. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of GoodRx by 70.4% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 149,945 shares of the company's stock valued at $697,000 after acquiring an additional 61,924 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in GoodRx by 12.2% in the 1st quarter. Assenagon Asset Management S.A. now owns 362,713 shares of the company's stock worth $1,600,000 after buying an additional 39,337 shares during the last quarter. CWA Asset Management Group LLC acquired a new stake in GoodRx in the 1st quarter worth about $292,000. Teacher Retirement System of Texas acquired a new stake in GoodRx in the 1st quarter worth about $218,000. Finally, Hohimer Wealth Management LLC boosted its stake in GoodRx by 8.2% in the 1st quarter. Hohimer Wealth Management LLC now owns 35,218 shares of the company's stock worth $155,000 after buying an additional 2,658 shares during the last quarter. Institutional investors and hedge funds own 63.77% of the company's stock.

GoodRx Company Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.